Fernando Camargo PhD

LIke ThisLIke ThisLIke ThisLIke ThisLIke This

Stem cell therapy for rare liver metabolic disorders

A subset of rare congenital metabolic liver diseases is amenable to treatment by the replacement of faulty liver cells. While cellular transplants have been attempted in patients, these have failed because the donor cells did nor persist or were immune rejected. Additionally, it is very difficult to find a donor liver from which to isolate cells for transplantation. We propose a new strategy to grow large numbers of liver progenitor cells from a patient so that these could be genetically corrected in the petri dish and reintroduced back into the same patient. These type of personalized stem cell therapy has the potential to produce long-lasting cures for these disorders.

Request an Appointment

If this is a medical emergency, please dial 9-1-1. This form should not be used in an emergency.

Patient Information
Date of Birth:
Contact Information
Appointment Details
Send RequestIf you do not see the specialty you are looking for, please call us at: 617-355-6000.International visitors should call International Health Services at +1-617-355-5209.
Please complete all required fields

This department is currently not accepting appointment requests online. Please call us at: 617-355-6000. International +1-617-355-6000.

This department is currently not accepting appointment requests online. Please call us at: 617-355-6000. International +1-617-355-6000.

Thank you.

Your request has been successfully submitted

You will be contacted within 1 business day.

If you have questions or would like more information, please call:

617-355-6000 +1-617-355-6000
Find a Doctor
Search by Clinician's Last Name or Specialty:
Select by Location:
Search by First Letter of Clinician's Last Name: *ABCDEFGHIJKLMNOPQRSTUVWXYZ
Condition & Treatments
Search for a Condition or Treatment:
View allSearch
The future of pediatrics will be forged by thinking differently, breaking paradigms and joining together in a shared vision of tackling the toughest challenges before us.”
- Sandra L. Fenwick, President and CEO